Resistance to HDM201 may arise from MDM2 amplification or overexpression, which could enhance p53 degradation in TP53 wild-type cells [65,66], though this is less relevant in p53-null models like GIST882 and GIST-T1. The gene discussed is MDM2; the disease is gastrointestinal stromal tumor.